Juha Lindner

943 total citations
20 papers, 622 citations indexed

About

Juha Lindner is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Juha Lindner has authored 20 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Juha Lindner's work include Parvovirus B19 Infection Studies (11 papers), Respiratory viral infections research (7 papers) and Viral gastroenteritis research and epidemiology (4 papers). Juha Lindner is often cited by papers focused on Parvovirus B19 Infection Studies (11 papers), Respiratory viral infections research (7 papers) and Viral gastroenteritis research and epidemiology (4 papers). Juha Lindner collaborates with scholars based in Germany, Netherlands and United Kingdom. Juha Lindner's co-authors include Susanne Modrow, J. A. A. Hoogkamp‐Korstanje, Jürgen J. Wenzel, Hugo Segerer, Sven Schimanski, J. H. Marcelis, Päivi Norja, Stefan R. Bornstein, Klaus Matschke and Friedhelm Kuethe and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Clinical Cancer Research.

In The Last Decade

Juha Lindner

19 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juha Lindner Germany 13 300 268 123 101 100 20 622
Yuki Asano‐Mori Japan 18 158 0.5× 433 1.6× 171 1.4× 251 2.5× 29 0.3× 74 888
Clementien L. Vermont Netherlands 17 165 0.6× 380 1.4× 183 1.5× 37 0.4× 87 0.9× 35 774
R Nategh Iran 18 310 1.0× 489 1.8× 104 0.8× 188 1.9× 218 2.2× 73 848
Supranee Buranapraditkun Thailand 19 326 1.1× 145 0.5× 302 2.5× 60 0.6× 35 0.3× 87 1.0k
Marine Meunier France 13 129 0.4× 113 0.4× 108 0.9× 73 0.7× 14 0.1× 24 717
Coretta van Leer‐Buter Netherlands 19 541 1.8× 415 1.5× 99 0.8× 56 0.6× 596 6.0× 50 1.2k
C. A. Benne Netherlands 15 366 1.2× 324 1.2× 308 2.5× 35 0.3× 27 0.3× 18 1.1k
Roberto Azar Israel 12 234 0.8× 257 1.0× 88 0.7× 25 0.2× 51 0.5× 19 530
Fatma Berri France 11 264 0.9× 213 0.8× 162 1.3× 44 0.4× 53 0.5× 19 580
Lenora M. Noroski United States 14 135 0.5× 158 0.6× 241 2.0× 24 0.2× 52 0.5× 26 549

Countries citing papers authored by Juha Lindner

Since Specialization
Citations

This map shows the geographic impact of Juha Lindner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juha Lindner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juha Lindner more than expected).

Fields of papers citing papers by Juha Lindner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juha Lindner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juha Lindner. The network helps show where Juha Lindner may publish in the future.

Co-authorship network of co-authors of Juha Lindner

This figure shows the co-authorship network connecting the top 25 collaborators of Juha Lindner. A scholar is included among the top collaborators of Juha Lindner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juha Lindner. Juha Lindner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rampling, R., Paul Mulholland, Allan James, et al.. (2016). A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research. 22(19). 4776–4785. 122 indexed citations
2.
Kuttruff, Sabrina, Toni Weinschenk, Oliver Schoor, et al.. (2012). Immune responses and association with clinical outcome of advanced colorectal cancer patients treated with the multi-peptide vaccine IMA910.. Journal of Clinical Oncology. 30(15_suppl). 2522–2522. 5 indexed citations
3.
Guido, Marcello, Antonella Zizza, Juha Lindner, et al.. (2011). Seroepidemiology of human bocavirus in Apulia, Italy. Clinical Microbiology and Infection. 18(4). E74–E76. 19 indexed citations
4.
5.
Lindner, Juha, et al.. (2009). Prevalence and clinical aspects of human bocavirus infection in children. Clinical Microbiology and Infection. 16(6). 633–639. 48 indexed citations
6.
Pongratz, Georg, Juha Lindner, Susanne Modrow, et al.. (2009). Persistent parvovirus B19 infection detected by specific CD4+ T‐cell responses in a patient with hepatitis and polyarthritis. Journal of Internal Medicine. 266(3). 296–301. 10 indexed citations
7.
Kuethe, Friedhelm, Juha Lindner, Klaus Matschke, et al.. (2009). Prevalence of Parvovirus B19 and Human Bocavirus DNA in the Heart of Patients with no Evidence of Dilated Cardiomyopathy or Myocarditis. Clinical Infectious Diseases. 49(11). 1660–1666. 101 indexed citations
8.
Enders, Martin, Juha Lindner, Jürgen J. Wenzel, et al.. (2009). No detection of human bocavirus in amniotic fluid samples from fetuses with hydrops or isolated effusions. Journal of Clinical Virology. 45(4). 300–303. 12 indexed citations
9.
Lindner, Juha, Sandra Zehentmeier, Annelie Plentz, et al.. (2008). Humoral Immune Response Against Human Bocavirus VP2 Virus-Like Particles. Viral Immunology. 21(4). 443–450. 50 indexed citations
10.
Gary, Regina, Tanja Bauer, Juha Lindner, et al.. (2008). Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein. PLoS Pathogens. 4(11). e1000198–e1000198. 12 indexed citations
11.
Lindner, Juha, Michel Noutsias, Dirk Laßner, et al.. (2008). Adaptive immune responses against parvovirus B19 in patients with myocardial disease. Journal of Clinical Virology. 44(1). 27–32. 19 indexed citations
12.
Lindner, Juha & Susanne Modrow. (2008). Human Bocavirus – A Novel Parvovirus to Infect Humans. Intervirology. 51(2). 116–122. 42 indexed citations
13.
Lindner, Juha, et al.. (2008). Clinical and epidemiological aspects of human bocavirus infection. Journal of Clinical Virology. 43(4). 391–395. 23 indexed citations
14.
Lindner, Juha, Sandra Zehentmeier, Rauli Franssila, et al.. (2008). CD4+T Helper Cell Responses against Human Bocavirus Viral Protein 2 Viruslike Particles in Healthy Adults. The Journal of Infectious Diseases. 198(11). 1677–1684. 25 indexed citations
15.
Lindner, Juha, Kathrin Saar, Daniel M. Altmann, et al.. (2005). CD4+ T‐Cell Responses Against the VP1‐Unique Region in Individuals with Recent and Persistent Parvovirus B19 Infection. Journal of Veterinary Medicine Series B. 52(7-8). 356–361. 10 indexed citations
16.
Steinmann, Gerhard, F. Rosenkaimer, Günther R. Adolf, et al.. (1992). Low incidence of antibody formation due to long-term interferon-?2c treatment of cancer patients. Journal of Molecular Medicine. 70(2). 136–41. 7 indexed citations
17.
Hoogkamp‐Korstanje, J. A. A., et al.. (1979). Composition and ecology of the human intestinal flora. Antonie van Leeuwenhoek. 45(1). 35–40. 23 indexed citations
18.
Lindner, Juha, et al.. (1979). Reaction of the Vaginal Flora to Ornidazol in Patients with Cervicitis. Chemotherapy. 25(4). 243–248. 1 indexed citations
19.
Lindner, Juha & J. H. Marcelis. (1978). Quantitative gas chromatography of Bacteroides species under different growth conditions. Antonie van Leeuwenhoek. 44(1). 1–14. 13 indexed citations
20.
Lindner, Juha, et al.. (1978). Quantitative Studies of the Vaginal Flora of Healthy Women and of Obstetric and Gynaecological Patients. Journal of Medical Microbiology. 11(3). 233–241. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuki Asano‐Mori Breakdown of academic impact, for papers by Clementien L. Vermont Breakdown of academic impact, for papers by R Nategh Breakdown of academic impact, for papers by Supranee Buranapraditkun Breakdown of academic impact, for papers by Marine Meunier Breakdown of academic impact, for papers by Coretta van Leer‐Buter Breakdown of academic impact, for papers by C. A. Benne Breakdown of academic impact, for papers by Roberto Azar Breakdown of academic impact, for papers by Fatma Berri Breakdown of academic impact, for papers by Lenora M. Noroski
Rankless by CCL
2026